Your company is already operating in Germany and you would now like to export worldwide?

Go to Trade

新闻稿

德国的生物制药产业：重返“世界药房”

This content belongs to

biopharma biopharma

历史上，德国有作为“世界的药房”的美誉，而BioNTech公司研发冠状病毒疫苗的成功使其重新成为全球制药业的焦点。生物制药约占德国所有药品批准量的60 %,这大约是180亿美元的营业额。在德国，几乎任何地方都能找到健康产业集群。国际制药和生物制药公司也从中受益。这一至关重要的健康产业将何去何从？您的企业如何从中受益？我们的新视频为您解答。请不要忘了点赞订阅并分享！

更多

 

 

 

This content belongs to

新闻稿
向上

All rights reserved. Any reproduction in whole or part only with express written permission. All efforts are made to ensure integrity of the content, however we are not liable for any mistakes that may occur.

© 2024 Germany Trade & Invest

Promoted by Federal Ministry for Economic Affairs and Climate Action in accordance with a German Parliament resolution.

登录

请用您的用户名和密码在此页面登录

忘记密码？